Related references
Note: Only part of the references are listed.Negligible-Cost and Weekend-Free Chemically Defined Human iPSC Culture
Hui-Hsuan Kuo et al.
STEM CELL REPORTS (2020)
Detection of Deleterious On-Target Effects after HDR-Mediated CRISPR Editing
Isabel Weisheit et al.
CELL REPORTS (2020)
Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice
Aline David-Silva et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2020)
Precise and Cost-Effective Nanopore Sequencing for Post-GWAS Fine-Mapping and Causal Variant Identification
Tarek Magdy et al.
ISCIENCE (2020)
Unraveling Difficult Answers: From Genotype to Phenotype in Coronary Artery Disease
Tarek Magdy et al.
CELL STEM CELL (2019)
beditor: A Computational Workflow for Designing Libraries of Guide RNAs for CRISPR-Mediated Base Editing
Rohan Dandage et al.
GENETICS (2019)
Short-lasting inhibition of hepatic uptake transporter OATP1B1 by tyrosine kinase inhibitor pazopanib
Takayuki Taguchi et al.
DRUG METABOLISM AND PHARMACOKINETICS (2019)
Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype
Daehwan Kim et al.
NATURE BIOTECHNOLOGY (2019)
Minimap2: pairwise alignment for nucleotide sequences
Heng Li
BIOINFORMATICS (2018)
NanoPack: visualizing and processing long-read sequencing data
Wouter De Coster et al.
BIOINFORMATICS (2018)
Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity
Monica Samuel Avila et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
The future role of pharmacogenomics in anticancer agent-induced cardiovascular toxicity
Tarek Magdy et al.
PHARMACOGENOMICS (2018)
Pretreatment With Rifampicin and Tyrosine Kinase Inhibitor Dasatinib Potentiates the Inhibitory Effects Toward OATP1B1-and OATP1B3-Mediated Transport
Sonia Pahwa et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Pharmacogenomic screening for anthracycline-induced cardiotoxicity in childhood cancer
Folefac Aminkeng et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Human iPS cell model of type 3 long QT syndrome recapitulates drug-based phenotype correction
Daniela Malan et al.
BASIC RESEARCH IN CARDIOLOGY (2016)
BCFtools/RoH: a hidden Markov model approach for detecting autozygosity from next-generation sequencing data
Vagheesh Narasimhan et al.
BIOINFORMATICS (2016)
Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity
Folefac Aminkeng et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Selective Inhibition of Human Equilibrative and Concentrative Nucleoside Transporters by BCR-ABL Kinase Inhibitors IDENTIFICATION OF KEY hENT1 AMINO ACID RESIDUES FOR INTERACTION WITH BCR-ABL KINASE INHIBITORS
Vijaya L. Damaraju et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Characterization of Long-Lasting Oatp Inhibition by Typical Inhibitor Cyclosporine A and In Vitro-In Vivo Discrepancy in Its Drug Interaction Potential in Rats
Takayuki Taguchi et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Engineering the AAVS1 locus for consistent and scalable transgene expression in human iPSCs and their differentiated derivatives
Fabian Oceguera-Yanez et al.
METHODS (2016)
deepTools2: a next generation web server for deep-sequencing data analysis
Fidel Ramirez et al.
NUCLEIC ACIDS RESEARCH (2016)
Validating the pharmacogenomics of chemotherapy-induced cardiotoxicity: What is missing?
Tarek Magdy et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Impact of Substrate-Dependent Inhibition on Renal Organic Cation Transporters hOCT2 and hMATE1/2-K-Mediated Drug Transport and Intracellular Accumulation
Jia Yin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Integrative analysis of 111 reference human epigenomes
Anshul Kundaje et al.
NATURE (2015)
The support of human genetic evidence for approved drug indications
Matthew R. Nelson et al.
NATURE GENETICS (2015)
A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer
Folefac Aminkeng et al.
NATURE GENETICS (2015)
Predicting effects of noncoding variants with deep learning-based sequence model
Jian Zhou et al.
NATURE METHODS (2015)
A complete bacterial genome assembled de novo using only nanopore sequencing data
Nicholas J. Loman et al.
NATURE METHODS (2015)
Structural basis for the blockade of MATE multidrug efflux pumps
Martha Radchenko et al.
NATURE COMMUNICATIONS (2015)
Novel codon-optimized mini-intronic plasmid for efficient, inexpensive, and xeno-free induction of pluripotency
Sebastian Diecke et al.
SCIENTIFIC REPORTS (2015)
A Facile Method to Establish Human Induced Pluripotent Stem Cells From Adult Blood Cells Under Feeder-Free and Xeno-Free Culture Conditions: A Clinically Compliant Approach
Bin-Kuan Chou et al.
STEM CELLS TRANSLATIONAL MEDICINE (2015)
Dose-Response Analysis Using R
Christian Ritz et al.
PLOS ONE (2015)
Inhibition of OATP1B1 by tyrosine kinase inhibitors: in vitro-in vivo correlations
S. Hu et al.
BRITISH JOURNAL OF CANCER (2014)
Verapamil decreases the glucose-lowering effect of metformin in healthy volunteers
Sung Kweon Cho et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies
Gang Wang et al.
NATURE MEDICINE (2014)
Chemically defined generation of human cardiomyocytes
Paul W. Burridge et al.
NATURE METHODS (2014)
Authentic Bosutinib Inhibits Triiodothyronine Transport by Monocarboxylate Transporter 8
Doreen Braun et al.
THYROID (2014)
Disease Modeling and Phenotypic Drug Screening for Diabetic Cardiomyopathy using Human Induced Pluripotent Stem Cells
Faye M. Drawnel et al.
CELL REPORTS (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
OAT1 and OAT3: Targets of drug-drug interaction between entecavir and JBP485
Qinghan Xu et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs
Changsung Kim et al.
NATURE (2013)
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran et al.
NATURE PROTOCOLS (2013)
Phase II and Phase III attrition rates 2011-2012
John Arrowsmith et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote
Yang Liao et al.
NUCLEIC ACIDS RESEARCH (2013)
Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children
H. Visscher et al.
PEDIATRIC BLOOD & CANCER (2013)
Assessment of Vandetanib as an Inhibitor of Various Human Renal Transporters: Inhibition of Multidrug and Toxin Extrusion as a Possible Mechanism Leading to Decreased Cisplatin and Creatinine Clearance
Hong Shen et al.
DRUG METABOLISM AND DISPOSITION (2013)
Long-lasting Inhibitory Effects of Cyclosporin A, but Not Tacrolimus, on OATP1B1-and OATP1B3-mediated Uptake
Yoshihisa Shitara et al.
DRUG METABOLISM AND PHARMACOKINETICS (2012)
Linking disease associations with regulatory information in the human genome
Marc A. Schaub et al.
GENOME RESEARCH (2012)
Tyrosine Kinase Inhibitors Noncompetitively Inhibit MCT8-Mediated Iodothyronine Transport
Doreen Braun et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children
Henk Visscher et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Systematic Localization of Common Disease-Associated Variation in Regulatory DNA
Matthew T. Maurano et al.
SCIENCE (2012)
Patient-Specific Induced Pluripotent Stem Cells as a Model for Familial Dilated Cardiomyopathy
Ning Sun et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Using Drosophila melanogaster as a Model for Genotoxic Chemical Mutational Studies with a New Program, SnpSift
Pablo Cingolani et al.
Frontiers in Genetics (2012)
The variant call format and VCFtools
Petr Danecek et al.
BIOINFORMATICS (2011)
Interactions of Tyrosine Kinase Inhibitors with Organic Cation Transporters and Multidrug and Toxic Compound Extrusion Proteins
Tsuyoshi Minematsu et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome
Masayuki Yazawa et al.
NATURE (2011)
Modelling the long QT syndrome with induced pluripotent stem cells
Ilanit Itzhaki et al.
NATURE (2011)
Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome
Xonia Carvajal-Vergara et al.
NATURE (2010)
Membrane transporters in drug development
Kathleen M. Giacomini et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
The Sequence Alignment/Map format and SAMtools
Heng Li et al.
BIOINFORMATICS (2009)
Recent advances in the understanding of the interaction of antidepressant drugs with serotonin and norepinephrine transporters
Jacob Andersen et al.
CHEMICAL COMMUNICATIONS (2009)
Organic Anion-Transporting Polypeptide 1B1 Mediates Transport of Gimatecan and BNP1350 and Can Be Inhibited by Several Classic ATP-Binding Cassette (ABC) B1 and/or ABCG2 Inhibitors
Roos L. Oostendorp et al.
DRUG METABOLISM AND DISPOSITION (2009)
Involvement of Human Multidrug and Toxin Extrusion 1 in the Drug Interaction between Cimetidine and Metformin in Renal Epithelial Cells
Masahiro Tsuda et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt
Steffen Durinck et al.
NATURE PROTOCOLS (2009)
Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome
Noemi Fusaki et al.
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2009)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
Drug-drug interaction between pitavastatin and various drugs via OATP1B1
Masaru Hirano et al.
DRUG METABOLISM AND DISPOSITION (2006)
Contribution of organic anion transporting polypeptide OAPT-C to hepatic elimination of the opioid pentapeptide analogue [D-Ala2,D-Leu5]-enkephalin
T Nozawa et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2003)
Congestive heart failure in patients treated with doxorubicin - A retrospective analysis of three trials
SM Swain et al.
CANCER (2003)
Influence of molecular structure on substrate binding to the human organic cation transporter, hOCT1
D Bednarczyk et al.
MOLECULAR PHARMACOLOGY (2003)
Inhibition of transporter-mediated hepatic uptake as a mechanism for drug-drug interaction between cerivastatin and cyclosporin A
Y Shitara et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Characterization of methotrexate transport and its drug interactions with human organic anion transporters
M Takeda et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver
SR Vavricka et al.
HEPATOLOGY (2002)
cDNA cloning, functional characterization, and tissue distribution of an alternatively spliced variant of organic cation transporter hOCT2 predominantly expressed in the human kidney
Y Urakami et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney
SH Cha et al.
MOLECULAR PHARMACOLOGY (2001)
Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6
Y Cui et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Two-step mechanism of phlorizin binding to the SGLT1 protein in the kidney
N Oulianova et al.
JOURNAL OF MEMBRANE BIOLOGY (2001)
Rifamycin SV and rifampicin exhibit differential inhibition of the hepatic rat organic anion transporting polypeptides, Oatp1 and Oatp2
K Fattinger et al.
HEPATOLOGY (2000)
Structural and functional characteristics and tissue distribution pattern of rat OCTN1, an organic cation transporter, cloned from placenta
X Wu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2000)
Pharmacokinetic study of the hepatobiliary transport of indomethacin
H Kouzuki et al.
PHARMACEUTICAL RESEARCH (2000)
Structure, function, and regional distribution of the organic cation transporter OCT3 in the kidney
XA Wu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2000)
Share Paper
